Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial - Turner, S; Cotton, S; Wood, J (Lancet Respir Med, 2022)
et al.